- Home
- RXT vs CATX Comparison
RXT vs CATX Comparison
Compare RXT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- CATX
- Stock Information
- Founded
- RXT 1998
- CATX 1983
- Country
- RXT United States
- CATX United States
- Employees
- RXT N/A
- CATX N/A
- Industry
- RXT EDP Services
- CATX Medical/Dental Instruments
- Sector
- RXT Technology
- CATX Health Care
- Exchange
- RXT Nasdaq
- CATX Nasdaq
- Market Cap
- RXT 274.9M
- CATX 239.0M
- IPO Year
- RXT 2020
- CATX N/A
- Fundamental
- Price
- RXT $1.17
- CATX $3.60
- Analyst Decision
- RXT Hold
- CATX Strong Buy
- Analyst Count
- RXT 5
- CATX 11
- Target Price
- RXT $1.58
- CATX $12.90
- AVG Volume (30 Days)
- RXT 824.1K
- CATX 712.3K
- Earning Date
- RXT 08-07-2025
- CATX 08-13-2025
- Dividend Yield
- RXT N/A
- CATX N/A
- EPS Growth
- RXT N/A
- CATX N/A
- EPS
- RXT N/A
- CATX N/A
- Revenue
- RXT $2,693,100,000.00
- CATX $1,235,000.00
- Revenue This Year
- RXT N/A
- CATX N/A
- Revenue Next Year
- RXT $1.48
- CATX $11.99
- P/E Ratio
- RXT N/A
- CATX N/A
- Revenue Growth
- RXT N/A
- CATX N/A
- 52 Week Low
- RXT $1.00
- CATX $1.60
- 52 Week High
- RXT $3.41
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- RXT 42.17
- CATX 44.08
- Support Level
- RXT $1.12
- CATX $3.66
- Resistance Level
- RXT $1.30
- CATX $4.08
- Average True Range (ATR)
- RXT 0.08
- CATX 0.26
- MACD
- RXT -0.01
- CATX -0.04
- Stochastic Oscillator
- RXT 22.73
- CATX 19.40
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.